Ellevest Inc’s Anika Therapeutics ANIK Stock Holding History

Ellevest Inc’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17	Closed	–	–	1841
2022 Q3	$0	Hold	17	–	–	﹤0.01%	1585
2022 Q2	$0	Hold	17	–	–	﹤0.01%	1380
2022 Q1	$0	Buy	+17	New	+$518	﹤0.01%	1396

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Ellevest Inc's ANIK Position: Q4 2022 in Review

Ellevest Inc sold out of Anika Therapeutics (ANIK) in Q4 2022, closing a stake of 17 shares.

Ellevest Inc first reported a position in ANIK in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 123 funds tracked by Wall St. Rank hold ANIK as of Q4 2022.

Ellevest Inc reported no remaining Anika Therapeutics position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 17 Anika Therapeutics shares in Q4 2022.
Ellevest Inc first reported a position in Anika Therapeutics in Q1 2022 and held it in 3 quarters.
Ellevest Inc's Anika Therapeutics position peaked at $0 in Q3 2022.
123 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.